International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
2018 · The Lancet · 2,008 citations
https://doi.org/10.1016/s0140-6736(18)30789-x
F
Florence Marliot
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
5.4K
Citations
22
h-index
30
i10-index
Florence Marliot is an academic researcher from Inserm. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Colorectal Cancer Surgical Treatments. The author has an h-index of 22, co-authored 68 publications.
Papers by this author
worksChemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
2020 · Nature Medicine · 192 citations
https://doi.org/10.1038/s41591-020-0882-8
MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies
2018 · Annals of Oncology · 9 citations
https://doi.org/10.1093/annonc/mdy493.011
The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?
2021 · Oncotarget · 9 citations
https://doi.org/10.18632/oncotarget.28100
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat